Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Cameron

Showing results (1401-1410 of 1,773) with videos related to

Pageof 178
Sort By:
Pain|June 15, 2023
Implementation of a risk-stratified, guideline-based clinical pathway of care to improve health outcomes following whiplash injury (Whiplash ImPaCT): a multicentre, randomized, controlled trialTrudy Rebbeck, Aila Nica Bandong, Andrew Leaver, et al.
Spinal Cord|June 17, 2020
Understanding how a community-based intervention for people with spinal cord injury in Bangladesh was delivered as part of a randomised controlled trial: a process evaluationHueiming Liu, Mohammad Sohrab Hossain, Md Shofiqul Islam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 4, 2014
Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 studyH Bonnefoi, W Jacot, M Saghatchian, et al.
BMJ Open|January 9, 2016
Community-based InterVentions to prevent serIous Complications (CIVIC) following spinal cord injury in Bangladesh: protocol of a randomised controlled trialMohammad S Hossain, Lisa A Harvey, Md Akhlasur Rahman, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2017
M344 promotes nonamyloidogenic amyloid precursor protein processing while normalizing Alzheimer's disease genes and improving memoryClaude-Henry Volmar, Hasib Salah-Uddin, Karolina J Janczura, et al.
Journal of Nutritional Science|August 4, 2020
A period of 10 weeks of increased protein consumption does not alter faecal microbiota or volatile metabolites in healthy older men: a randomised controlled trialS M Mitchell, E J McKenzie, C J Mitchell, et al.
Scientific Reports|October 27, 2019
Longest terrestrial migrations and movements around the worldKyle Joly, Eliezer Gurarie, Mathew S Sorum, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 26, 2021
Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysisG Curigliano, V Mueller, V Borges, et al.
BMC Cancer|March 16, 2022
Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinomaR Mercieca-Bebber, E H Barnes, K Wilson, et al.
BMC Neurology|October 24, 2024
A 5-year natural history study in LAMA2-related muscular dystrophy and SELENON-related myopathy: the Extended LAST STRONG studyE C M de Laat, S L S Houwen-van Opstal, K Bouman, et al.
Pageof 178

Showing results (1401-1410 of 1,773) with videos related to

Sort By:
Pageof 178
Pain|June 15, 2023
Implementation of a risk-stratified, guideline-based clinical pathway of care to improve health outcomes following whiplash injury (Whiplash ImPaCT): a multicentre, randomized, controlled trialTrudy Rebbeck, Aila Nica Bandong, Andrew Leaver, et al.
Spinal Cord|June 17, 2020
Understanding how a community-based intervention for people with spinal cord injury in Bangladesh was delivered as part of a randomised controlled trial: a process evaluationHueiming Liu, Mohammad Sohrab Hossain, Md Shofiqul Islam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 4, 2014
Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 studyH Bonnefoi, W Jacot, M Saghatchian, et al.
BMJ Open|January 9, 2016
Community-based InterVentions to prevent serIous Complications (CIVIC) following spinal cord injury in Bangladesh: protocol of a randomised controlled trialMohammad S Hossain, Lisa A Harvey, Md Akhlasur Rahman, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2017
M344 promotes nonamyloidogenic amyloid precursor protein processing while normalizing Alzheimer's disease genes and improving memoryClaude-Henry Volmar, Hasib Salah-Uddin, Karolina J Janczura, et al.
Journal of Nutritional Science|August 4, 2020
A period of 10 weeks of increased protein consumption does not alter faecal microbiota or volatile metabolites in healthy older men: a randomised controlled trialS M Mitchell, E J McKenzie, C J Mitchell, et al.
Scientific Reports|October 27, 2019
Longest terrestrial migrations and movements around the worldKyle Joly, Eliezer Gurarie, Mathew S Sorum, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 26, 2021
Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysisG Curigliano, V Mueller, V Borges, et al.
BMC Cancer|March 16, 2022
Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinomaR Mercieca-Bebber, E H Barnes, K Wilson, et al.
BMC Neurology|October 24, 2024
A 5-year natural history study in LAMA2-related muscular dystrophy and SELENON-related myopathy: the Extended LAST STRONG studyE C M de Laat, S L S Houwen-van Opstal, K Bouman, et al.
Pageof 178